Status:
UNKNOWN
Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock
Lead Sponsor:
Aragon Institute of Health Sciences
Collaborating Sponsors:
Ministerio de Sanidad, Servicios Sociales e Igualdad
Conditions:
Severe Sepsis
Septic Shock
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
OBJECTIVES. To establish the therapeutic efficiency of melatonin in adult patients with severe sepsis and septic shock. Specifically: 1. To evaluate the survival to 28 days of mechanical assisted ve...
Detailed Description
This study will be done in the Hospital Clinico Lozano Blesa (Zaragoza, Spain), promoted by the Health Science Aragon Institute and its principal investigator is F. Agustín García Gil (Surgical Servic...
Eligibility Criteria
Inclusion
- patients (males and females) over 18 years who meet the diagnostic criteria for severe sepsis or septic shock secondary to community-acquired pneumonia or hospital and or intra-abdominal infection
Exclusion
- Patient with more than 24 hours from the first documentation of organ dysfunction
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01858909
Start Date
May 1 2013
End Date
December 1 2013
Last Update
May 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínico Universitario Lozano Blesa
Zaragoza, Zaragoza, Spain, 50009